Uploaded August 2025 | Updated September 2026, 1 week ago
Dr. Timofey Glinin, postdoc at UCSF and co-founder of First Approval, reveals a shocking reality: longevity researchers rank lack of data access as a bigger barrier than funding shortages. With only 30-50% of biological studies being reproducible, we're losing decades of potential breakthroughs.
In this eye-opening conversation, we explore:
Why the longevity field prioritizes data access over regulatory changes
The reproducibility crisis plaguing biological research
How First Approval is revolutionizing scientific data publishing
Their groundbreaking $7,500 student competition rewarding excellent datasets
The future of collaborative science through open data sharing
Tim's unique perspective comes from over 10 years in aging research, including co-creating the Open Genes database with 2,400+ aging-related genes. Now he's tackling the infrastructure problems that slow scientific progress.
Key Resources:
First Approval Platform: firstapproval.io
Student Biological Data Competition (Deadline: September 15th)
firstapproval.io/contest
Support the channel:
PayPal: paypal.me/sheekeyscience
Patreon: patreon.com/TheSheekeyScienceShow
Follow me: twitter.com/EleanorSheekey
Timestamps:
00:00 - Introduction: The hidden barriers to longevity breakthroughs
02:27 - The shocking truth: Why 70% of biology studies can't be reproduced
15:23 - Raw data vs processed data: What scientists actually need to share
35:14 - First Approval's $7,500 competition: Rewarding datasets, not just papers
48:27 - The future of science: Data sharing vs traditional journal publishing
Disclaimer: This content is educational and not medical advice.
Please note that The Sheekey Science Show is distinct from Eleanor Sheekey's teaching and research roles. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Sheekey Science Show and guests assume no liability for the application of the information discussed.
Dr. Timofey Glinin, postdoc at UCSF and co-founder of First Approval, reveals a shocking reality: longevity researchers rank lack of data access as a bigger barrier than funding shortages. With only 30-50% of biological studies being reproducible, we're losing decades of potential breakthroughs.
In this eye-opening conversation, we explore:
Why the longevity field prioritizes data access over regulatory changes
The reproducibility crisis plaguing biological research
How First Approval is revolutionizing scientific data publishing
Their groundbreaking $7,500 student competition rewarding excellent datasets
The future of collaborative science through open data sharing
Tim's unique perspective comes from over 10 years in aging research, including co-creating the Open Genes database with 2,400+ aging-related genes. Now he's tackling the infrastructure problems that slow scientific progress.
Key Resources:
First Approval Platform: firstapproval.io
Student Biological Data Competition (Deadline: September 15th)
firstapproval.io/contest
Support the channel:
PayPal: paypal.me/sheekeyscience
Patreon: patreon.com/TheSheekeyScienceShow
Follow me: twitter.com/EleanorSheekey
Timestamps:
00:00 - Introduction: The hidden barriers to longevity breakthroughs
02:27 - The shocking truth: Why 70% of biology studies can't be reproduced
15:23 - Raw data vs processed data: What scientists actually need to share
35:14 - First Approval's $7,500 competition: Rewarding datasets, not just papers
48:27 - The future of science: Data sharing vs traditional journal publishing
Disclaimer: This content is educational and not medical advice.
Please note that The Sheekey Science Show is distinct from Eleanor Sheekey's teaching and research roles. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Sheekey Science Show and guests assume no liability for the application of the information discussed.
